TXG Stock Recent News

Caroline Donally brings extensive mining sector experience in commerce and financial markets Toronto, Ontario--(Newsfile Corp. - September 23, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to announce the addition of Caroline Donally CA(SA) to its Board of Directors ("the Board") effective October 1, 2024. Rick Howes, Chair of the Board, stated: "Caroline is an experienced executive and director with a proven track record of value creation in the mining sector.

Updated mine plan shows a robust long-term production profile that comes with a low risk, capital efficient development plan for EPO (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - September 4, 2024) -  Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports an updated life-of-mine plan for the Morelos Complex which incorporates the EPO underground deposit following completion of an internal pre-feasibility study on the deposit. The Company will be hosting an Analyst & Investor Day tomorrow morning at 10:00 AM ET to discuss the results of the study along with an update on the wider business, including the Company's multi-year exploration strategy.

PLEASANTON, Calif. , Sept. 3, 2024 /PRNewswire/ --  10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments.

Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that on the morning of August 29th, a fatal injury occurred involving a contract worker within the Guajes Tunnel. Jody Kuzenko, President & CEO of Torex, stated: "We are deeply saddened by the death of a 40-year-old male contractor who suffered fatal injuries while working in the Guajes Tunnel and our thoughts are with his family and friends.

PLEASANTON, Calif. , Aug. 22, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 10:45 a.m.

10x Genomics, Inc. (NASDAQ:TXG ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Cassie Corneau - Director-Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer and Co-Founder Justin McAnear - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel Tejas Savant - Morgan Stanley Madeline Mollman - Wolfe Research Marta Zaremba - JPMorgan Kyle Boucher - TD Cowen Kyle Mikson - Canaccord Genuity Michael Ryskin - Bank of America Matthew Sykes - Goldman Sachs Matt Larew - William Blair Luke Sergott - Barclays Operator Thank you for standing by. My name is Kayla and I will be your conference operator today.

While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

10x Genomics (TXG) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.53 per share a year ago.

PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team.

PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2024.